CUFF-assisted Colonoscopy vs Standard Colonoscopy

USE OF ENDOCUFF SECOND GENERATION IN THE COLIC POLYPS DETECTION: HISTORIC COHORTE PROSPECTIVE COMPARATIVE

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03758872

Acronym

CUFF-TROCADERO

Enrollment

1034

Registered

2018-11-29

Start date

2018-10-25

Completion date

2019-09-26

Last updated

2021-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyp, Colonoscopy

Brief summary

The goal of this study is to evaluate the interest of second-generation Endocuff Vision (ECV) to improve Adenoma detection rate and / or Polyp detection rate in routine colonoscopy. This is a prospective comparative cohort, on 1034 patients, 517 patients with ECV in prospective group and 517 without ECV in retrospective group

Interventions

DIAGNOSTIC_TESTcuff assisted colonoscopy(with cuff use of endocuff vision second generation)

this is a cohort prospective comparative, a group without cuff in 2017, 517 patient included in the retrospective phase, and in 2018, 517 patient will be included in the prospective phase with CUFF for detecting polyps

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient scheduled for total colonoscopic exploration, during the period study * Patient over or equal to 18 years * ASA 1, ASA 2, ASA 3 * No participation in another clinical study * Certificate of non opposition signed

Exclusion criteria

* Patient under 18 years old * ASA 4, ASA 5 * Pregnant woman * Patient with coagulation abnormalities preventing polypectomy: prothrombin level \<50%, -Platelets \<50000 / mm3, effective anti-coagulation in progress, clopidogrel in progress. * Inflammatory bowel disease * Known colonic stenosis * Diverticulitis less than 6 weeks old * Patient unable to give consent or protected by law * Opposition expressed for inclusion in the study

Design outcomes

Primary

Measure	Time frame
detection of polyp or adenoma with cuff	during procedure

Secondary

Measure	Time frame	Description
POLYP DETECTION RATE	during procedure	—
morbidity : perforation rate	21 DAYS AFTER PROCEDURE	—
CAECAL INTUBATION RATE	DURING PROCEDURE	—
TIME TO REACH CAECUM	DURING PROCEDURE	SEC
WITHDRAWAL TIME	DURING PROCEDURE	SEC

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026